VulnerabilityModified
CVE-2023-41149
F-RevoCRM version7.3.7 and version7.3.8 contains an OS command injection vulnerability.
CRITICAL 9.8EPSS 1.49%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (1.49%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
F-RevoCRM version7.3.7 and version7.3.8 contains an OS command injection vulnerability. If this vulnerability is exploited, an attacker who can access the product may execute an arbitrary OS command on the server where the product is running.
- CVSS 3.1
- 9.8 CRITICALCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 1.49% probability · 73th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-78
- Affected
- f-revocrm/f-revocrm
- Source
- vultures@jpcert.or.jp
References
- http://jvn.jp/en/jp/JVN78113802/Third Party Advisory
- https://f-revocrm.jp/2023/08/9394/Vendor Advisory
- http://jvn.jp/en/jp/JVN78113802/Third Party Advisory
- https://f-revocrm.jp/2023/08/9394/Vendor Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.